top of page
![Logo Aptol](https://static.wixstatic.com/media/08be47_8f40738dd0f84d4c8e1ba708d2f9382b~mv2.png/v1/crop/x_2,y_0,w_968,h_195/fill/w_259,h_52,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Logo%20Aptol%5B57%5D_edited.png)
![Sphere on Spiral Stairs](https://static.wixstatic.com/media/11062b_952485dce28e4eac9e9f09d63fdc9ada~mv2.jpg/v1/fill/w_99,h_99,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/11062b_952485dce28e4eac9e9f09d63fdc9ada~mv2.jpg)
Aptol Pharma is developing functional cures for a range of autoimmune diseases
with significant unmet medical need, leveraging our peptide-aptamer nanoparticle platform
We are developing our proprietary technology to the ultimate benefit of patients
Get in touch
Aptol Pharma ApS
Thad Jones Vej 6 st th, 2450 Copenhagen SV
addt@aptolpharma.com | Tel: +45 26784520
CVR number: 39308967
bottom of page